nodes	percent_of_prediction	percent_of_DWPC	metapath
Celecoxib—Sulfaphenazole—Sulfasalazine—rheumatoid arthritis	0.181	1	CrCrCtD
Celecoxib—hematologic cancer—Methylprednisolone—rheumatoid arthritis	0.0936	0.238	CpDpCtD
Celecoxib—PTGS2—rheumatoid arthritis	0.0582	0.529	CbGaD
Celecoxib—ALB—rheumatoid arthritis	0.0518	0.471	CbGaD
Celecoxib—kidney cancer—Hydrocortisone—rheumatoid arthritis	0.05	0.127	CpDpCtD
Celecoxib—colon cancer—Betamethasone—rheumatoid arthritis	0.0422	0.107	CpDpCtD
Celecoxib—colon cancer—Dexamethasone—rheumatoid arthritis	0.0422	0.107	CpDpCtD
Celecoxib—prostate cancer—Hydrocortisone—rheumatoid arthritis	0.0362	0.0917	CpDpCtD
Celecoxib—kidney cancer—Betamethasone—rheumatoid arthritis	0.0305	0.0774	CpDpCtD
Celecoxib—kidney cancer—Dexamethasone—rheumatoid arthritis	0.0305	0.0774	CpDpCtD
Celecoxib—ALB—Auranofin—rheumatoid arthritis	0.0249	0.167	CbGbCtD
Celecoxib—prostate cancer—Dexamethasone—rheumatoid arthritis	0.0221	0.056	CpDpCtD
Celecoxib—prostate cancer—Betamethasone—rheumatoid arthritis	0.0221	0.056	CpDpCtD
Celecoxib—PTGS2—Triamcinolone—rheumatoid arthritis	0.0157	0.106	CbGbCtD
Celecoxib—PTGS2—Sulfasalazine—rheumatoid arthritis	0.0157	0.106	CbGbCtD
Celecoxib—PTGS2—Betamethasone—rheumatoid arthritis	0.0135	0.0907	CbGbCtD
Celecoxib—osteoarthritis—Methylprednisolone—rheumatoid arthritis	0.0124	0.0315	CpDpCtD
Celecoxib—osteoarthritis—Prednisone—rheumatoid arthritis	0.0124	0.0315	CpDpCtD
Celecoxib—ABCC4—Methotrexate—rheumatoid arthritis	0.0107	0.0721	CbGbCtD
Celecoxib—CYP2C9—Leflunomide—rheumatoid arthritis	0.00864	0.0581	CbGbCtD
Celecoxib—ALB—Prednisone—rheumatoid arthritis	0.00792	0.0533	CbGbCtD
Celecoxib—PTGS2—Dexamethasone—rheumatoid arthritis	0.00784	0.0527	CbGbCtD
Celecoxib—CA6—submandibular gland—rheumatoid arthritis	0.00678	0.29	CbGeAlD
Celecoxib—CYP3A4—Ergocalciferol—rheumatoid arthritis	0.00555	0.0374	CbGbCtD
Celecoxib—CYP3A4—Methylprednisolone—rheumatoid arthritis	0.00409	0.0276	CbGbCtD
Celecoxib—CYP2C9—Cyclosporine—rheumatoid arthritis	0.00404	0.0272	CbGbCtD
Celecoxib—ALB—Methotrexate—rheumatoid arthritis	0.00397	0.0267	CbGbCtD
Celecoxib—CYP2D6—Cyclosporine—rheumatoid arthritis	0.0037	0.0249	CbGbCtD
Celecoxib—CYP3A4—Triamcinolone—rheumatoid arthritis	0.0031	0.0209	CbGbCtD
Celecoxib—CYP2C9—Dexamethasone—rheumatoid arthritis	0.00266	0.0179	CbGbCtD
Celecoxib—CYP3A4—Betamethasone—rheumatoid arthritis	0.00266	0.0179	CbGbCtD
Celecoxib—CYP3A4—Prednisolone—rheumatoid arthritis	0.00263	0.0177	CbGbCtD
Celecoxib—CYP3A4—Hydrocortisone—rheumatoid arthritis	0.00249	0.0168	CbGbCtD
Celecoxib—CYP3A4—Prednisone—rheumatoid arthritis	0.00248	0.0167	CbGbCtD
Celecoxib—CA6—saliva—rheumatoid arthritis	0.00244	0.104	CbGeAlD
Celecoxib—CYP2D6—Dexamethasone—rheumatoid arthritis	0.00244	0.0164	CbGbCtD
Celecoxib—CYP3A4—Cyclosporine—rheumatoid arthritis	0.00235	0.0158	CbGbCtD
Celecoxib—CYP3A4—Dexamethasone—rheumatoid arthritis	0.00155	0.0104	CbGbCtD
Celecoxib—ORM1—saliva—rheumatoid arthritis	0.0013	0.0555	CbGeAlD
Celecoxib—CA6—exocrine gland—rheumatoid arthritis	0.00123	0.0527	CbGeAlD
Celecoxib—PTGS2—skeletal joint—rheumatoid arthritis	0.00086	0.0367	CbGeAlD
Celecoxib—PDPK1—lymphoid tissue—rheumatoid arthritis	0.000683	0.0292	CbGeAlD
Celecoxib—PDPK1—digestive system—rheumatoid arthritis	0.000675	0.0288	CbGeAlD
Celecoxib—PTGS2—synovial membrane of synovial joint—rheumatoid arthritis	0.000653	0.0279	CbGeAlD
Celecoxib—CA6—parotid gland—rheumatoid arthritis	0.000642	0.0275	CbGeAlD
Celecoxib—CA6—saliva-secreting gland—rheumatoid arthritis	0.000615	0.0263	CbGeAlD
Celecoxib—PTGS2—cartilage tissue—rheumatoid arthritis	0.000578	0.0247	CbGeAlD
Celecoxib—MAPK14—connective tissue—rheumatoid arthritis	0.0005	0.0214	CbGeAlD
Celecoxib—CA2—exocrine gland—rheumatoid arthritis	0.000425	0.0182	CbGeAlD
Celecoxib—CA12—connective tissue—rheumatoid arthritis	0.000379	0.0162	CbGeAlD
Celecoxib—CA9—digestive system—rheumatoid arthritis	0.00037	0.0158	CbGeAlD
Celecoxib—MAPK14—lymphoid tissue—rheumatoid arthritis	0.000365	0.0156	CbGeAlD
Celecoxib—MAPK14—digestive system—rheumatoid arthritis	0.000361	0.0154	CbGeAlD
Celecoxib—CA9—tendon—rheumatoid arthritis	0.000352	0.0151	CbGeAlD
Celecoxib—MAPK14—tendon—rheumatoid arthritis	0.000343	0.0147	CbGeAlD
Celecoxib—CA14—tendon—rheumatoid arthritis	0.000334	0.0143	CbGeAlD
Celecoxib—CA12—digestive system—rheumatoid arthritis	0.000274	0.0117	CbGeAlD
Celecoxib—CA4—parotid gland—rheumatoid arthritis	0.000267	0.0114	CbGeAlD
Celecoxib—CA4—saliva-secreting gland—rheumatoid arthritis	0.000255	0.0109	CbGeAlD
Celecoxib—CA5B—tendon—rheumatoid arthritis	0.000234	0.00999	CbGeAlD
Celecoxib—CA2—parotid gland—rheumatoid arthritis	0.000221	0.00945	CbGeAlD
Celecoxib—CA2—saliva-secreting gland—rheumatoid arthritis	0.000212	0.00905	CbGeAlD
Celecoxib—CA2—connective tissue—rheumatoid arthritis	0.000195	0.00832	CbGeAlD
Celecoxib—ABCC4—digestive system—rheumatoid arthritis	0.000184	0.00788	CbGeAlD
Celecoxib—PTGS2—Fluocinonide—Methylprednisolone—rheumatoid arthritis	0.000177	0.159	CbGdCrCtD
Celecoxib—ABCC4—tendon—rheumatoid arthritis	0.000176	0.0075	CbGeAlD
Celecoxib—PTGS2—Fluocinonide—Betamethasone—rheumatoid arthritis	0.000174	0.156	CbGdCrCtD
Celecoxib—PTGS2—Fluocinonide—Dexamethasone—rheumatoid arthritis	0.000174	0.156	CbGdCrCtD
Celecoxib—PTGS2—Fluocinonide—Triamcinolone—rheumatoid arthritis	0.00017	0.153	CbGdCrCtD
Celecoxib—CA4—digestive system—rheumatoid arthritis	0.00017	0.00725	CbGeAlD
Celecoxib—CA4—tendon—rheumatoid arthritis	0.000161	0.0069	CbGeAlD
Celecoxib—PTGS2—connective tissue—rheumatoid arthritis	0.000144	0.00614	CbGeAlD
Celecoxib—CA2—lymphoid tissue—rheumatoid arthritis	0.000142	0.00608	CbGeAlD
Celecoxib—CA2—digestive system—rheumatoid arthritis	0.000141	0.00601	CbGeAlD
Celecoxib—CA2—tendon—rheumatoid arthritis	0.000134	0.00572	CbGeAlD
Celecoxib—CYP2C9—digestive system—rheumatoid arthritis	0.000119	0.00508	CbGeAlD
Celecoxib—PTGS2—Fluticasone Propionate—Methylprednisolone—rheumatoid arthritis	0.000107	0.0958	CbGdCrCtD
Celecoxib—PTGS2—Fluticasone Propionate—Dexamethasone—rheumatoid arthritis	0.000105	0.0942	CbGdCrCtD
Celecoxib—PTGS2—Fluticasone Propionate—Betamethasone—rheumatoid arthritis	0.000105	0.0942	CbGdCrCtD
Celecoxib—PTGS2—lymphoid tissue—rheumatoid arthritis	0.000105	0.00449	CbGeAlD
Celecoxib—PTGS2—digestive system—rheumatoid arthritis	0.000104	0.00444	CbGeAlD
Celecoxib—PTGS2—Fluticasone Propionate—Triamcinolone—rheumatoid arthritis	0.000103	0.0921	CbGdCrCtD
Celecoxib—PTGS2—tendon—rheumatoid arthritis	9.88e-05	0.00422	CbGeAlD
Celecoxib—Etoricoxib—PTGS2—rheumatoid arthritis	9.62e-05	1	CrCbGaD
Celecoxib—CYP3A4—digestive system—rheumatoid arthritis	9.07e-05	0.00388	CbGeAlD
Celecoxib—CYP2D6—digestive system—rheumatoid arthritis	8.93e-05	0.00381	CbGeAlD
Celecoxib—Musculoskeletal discomfort—Hydrocortisone—rheumatoid arthritis	2.6e-05	0.000344	CcSEcCtD
Celecoxib—Hyperhidrosis—Triamcinolone—rheumatoid arthritis	2.6e-05	0.000344	CcSEcCtD
Celecoxib—Agranulocytosis—Methotrexate—rheumatoid arthritis	2.6e-05	0.000344	CcSEcCtD
Celecoxib—Hyperhidrosis—Methylprednisolone—rheumatoid arthritis	2.59e-05	0.000343	CcSEcCtD
Celecoxib—Insomnia—Hydrocortisone—rheumatoid arthritis	2.58e-05	0.000342	CcSEcCtD
Celecoxib—Hypertension—Dexamethasone—rheumatoid arthritis	2.58e-05	0.000341	CcSEcCtD
Celecoxib—Hypertension—Betamethasone—rheumatoid arthritis	2.58e-05	0.000341	CcSEcCtD
Celecoxib—Paraesthesia—Hydrocortisone—rheumatoid arthritis	2.56e-05	0.000339	CcSEcCtD
Celecoxib—Urticaria—Cyclosporine—rheumatoid arthritis	2.55e-05	0.000338	CcSEcCtD
Celecoxib—Myalgia—Betamethasone—rheumatoid arthritis	2.55e-05	0.000337	CcSEcCtD
Celecoxib—Myalgia—Dexamethasone—rheumatoid arthritis	2.55e-05	0.000337	CcSEcCtD
Celecoxib—Abdominal pain—Cyclosporine—rheumatoid arthritis	2.54e-05	0.000336	CcSEcCtD
Celecoxib—Body temperature increased—Cyclosporine—rheumatoid arthritis	2.54e-05	0.000336	CcSEcCtD
Celecoxib—Anxiety—Dexamethasone—rheumatoid arthritis	2.54e-05	0.000335	CcSEcCtD
Celecoxib—Anxiety—Betamethasone—rheumatoid arthritis	2.54e-05	0.000335	CcSEcCtD
Celecoxib—Dyspepsia—Hydrocortisone—rheumatoid arthritis	2.51e-05	0.000332	CcSEcCtD
Celecoxib—Haemoglobin—Methotrexate—rheumatoid arthritis	2.51e-05	0.000332	CcSEcCtD
Celecoxib—Hepatitis—Methotrexate—rheumatoid arthritis	2.5e-05	0.000331	CcSEcCtD
Celecoxib—Haemorrhage—Methotrexate—rheumatoid arthritis	2.5e-05	0.000331	CcSEcCtD
Celecoxib—Decreased appetite—Hydrocortisone—rheumatoid arthritis	2.48e-05	0.000328	CcSEcCtD
Celecoxib—Pharyngitis—Methotrexate—rheumatoid arthritis	2.48e-05	0.000328	CcSEcCtD
Celecoxib—Nausea—Leflunomide—rheumatoid arthritis	2.47e-05	0.000327	CcSEcCtD
Celecoxib—Urinary tract disorder—Methotrexate—rheumatoid arthritis	2.47e-05	0.000326	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	2.47e-05	0.000326	CcSEcCtD
Celecoxib—Fatigue—Hydrocortisone—rheumatoid arthritis	2.46e-05	0.000326	CcSEcCtD
Celecoxib—Vision blurred—Prednisone—rheumatoid arthritis	2.45e-05	0.000324	CcSEcCtD
Celecoxib—Urethral disorder—Methotrexate—rheumatoid arthritis	2.45e-05	0.000324	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Triamcinolone—rheumatoid arthritis	2.45e-05	0.000324	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Methylprednisolone—rheumatoid arthritis	2.44e-05	0.000323	CcSEcCtD
Celecoxib—Anaphylactic shock—Dexamethasone—rheumatoid arthritis	2.44e-05	0.000323	CcSEcCtD
Celecoxib—Oedema—Betamethasone—rheumatoid arthritis	2.44e-05	0.000323	CcSEcCtD
Celecoxib—Anaphylactic shock—Betamethasone—rheumatoid arthritis	2.44e-05	0.000323	CcSEcCtD
Celecoxib—Oedema—Dexamethasone—rheumatoid arthritis	2.44e-05	0.000323	CcSEcCtD
Celecoxib—Insomnia—Triamcinolone—rheumatoid arthritis	2.43e-05	0.000322	CcSEcCtD
Celecoxib—Insomnia—Methylprednisolone—rheumatoid arthritis	2.43e-05	0.000321	CcSEcCtD
Celecoxib—Infection—Betamethasone—rheumatoid arthritis	2.42e-05	0.000321	CcSEcCtD
Celecoxib—Infection—Dexamethasone—rheumatoid arthritis	2.42e-05	0.000321	CcSEcCtD
Celecoxib—Paraesthesia—Triamcinolone—rheumatoid arthritis	2.41e-05	0.000319	CcSEcCtD
Celecoxib—Feeling abnormal—Prednisolone—rheumatoid arthritis	2.41e-05	0.000319	CcSEcCtD
Celecoxib—Paraesthesia—Methylprednisolone—rheumatoid arthritis	2.41e-05	0.000319	CcSEcCtD
Celecoxib—Anaemia—Prednisone—rheumatoid arthritis	2.41e-05	0.000318	CcSEcCtD
Celecoxib—Shock—Betamethasone—rheumatoid arthritis	2.4e-05	0.000317	CcSEcCtD
Celecoxib—Shock—Dexamethasone—rheumatoid arthritis	2.4e-05	0.000317	CcSEcCtD
Celecoxib—Dyspnoea—Triamcinolone—rheumatoid arthritis	2.4e-05	0.000317	CcSEcCtD
Celecoxib—Nervous system disorder—Betamethasone—rheumatoid arthritis	2.39e-05	0.000316	CcSEcCtD
Celecoxib—Nervous system disorder—Dexamethasone—rheumatoid arthritis	2.39e-05	0.000316	CcSEcCtD
Celecoxib—Thrombocytopenia—Dexamethasone—rheumatoid arthritis	2.39e-05	0.000316	CcSEcCtD
Celecoxib—Thrombocytopenia—Betamethasone—rheumatoid arthritis	2.39e-05	0.000316	CcSEcCtD
Celecoxib—Tachycardia—Betamethasone—rheumatoid arthritis	2.38e-05	0.000315	CcSEcCtD
Celecoxib—Tachycardia—Dexamethasone—rheumatoid arthritis	2.38e-05	0.000315	CcSEcCtD
Celecoxib—Angioedema—Prednisone—rheumatoid arthritis	2.38e-05	0.000315	CcSEcCtD
Celecoxib—Hypersensitivity—Cyclosporine—rheumatoid arthritis	2.37e-05	0.000313	CcSEcCtD
Celecoxib—Dyspepsia—Triamcinolone—rheumatoid arthritis	2.37e-05	0.000313	CcSEcCtD
Celecoxib—Erythema multiforme—Methotrexate—rheumatoid arthritis	2.36e-05	0.000313	CcSEcCtD
Celecoxib—Dyspepsia—Methylprednisolone—rheumatoid arthritis	2.36e-05	0.000312	CcSEcCtD
Celecoxib—Hyperhidrosis—Betamethasone—rheumatoid arthritis	2.36e-05	0.000312	CcSEcCtD
Celecoxib—Hyperhidrosis—Dexamethasone—rheumatoid arthritis	2.36e-05	0.000312	CcSEcCtD
Celecoxib—Feeling abnormal—Hydrocortisone—rheumatoid arthritis	2.35e-05	0.000311	CcSEcCtD
Celecoxib—Vertigo—Prednisone—rheumatoid arthritis	2.34e-05	0.000309	CcSEcCtD
Celecoxib—Eye disorder—Methotrexate—rheumatoid arthritis	2.34e-05	0.000309	CcSEcCtD
Celecoxib—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	2.34e-05	0.000309	CcSEcCtD
Celecoxib—Syncope—Prednisone—rheumatoid arthritis	2.34e-05	0.000309	CcSEcCtD
Celecoxib—Tinnitus—Methotrexate—rheumatoid arthritis	2.33e-05	0.000308	CcSEcCtD
Celecoxib—Anorexia—Dexamethasone—rheumatoid arthritis	2.33e-05	0.000308	CcSEcCtD
Celecoxib—Anorexia—Betamethasone—rheumatoid arthritis	2.33e-05	0.000308	CcSEcCtD
Celecoxib—Urticaria—Prednisolone—rheumatoid arthritis	2.32e-05	0.000307	CcSEcCtD
Celecoxib—Cardiac disorder—Methotrexate—rheumatoid arthritis	2.32e-05	0.000307	CcSEcCtD
Celecoxib—Fatigue—Triamcinolone—rheumatoid arthritis	2.32e-05	0.000307	CcSEcCtD
Celecoxib—Fatigue—Methylprednisolone—rheumatoid arthritis	2.31e-05	0.000306	CcSEcCtD
Celecoxib—Asthenia—Cyclosporine—rheumatoid arthritis	2.31e-05	0.000305	CcSEcCtD
Celecoxib—Loss of consciousness—Prednisone—rheumatoid arthritis	2.29e-05	0.000303	CcSEcCtD
Celecoxib—Pruritus—Cyclosporine—rheumatoid arthritis	2.27e-05	0.000301	CcSEcCtD
Celecoxib—Urticaria—Hydrocortisone—rheumatoid arthritis	2.27e-05	0.0003	CcSEcCtD
Celecoxib—Angiopathy—Methotrexate—rheumatoid arthritis	2.27e-05	0.0003	CcSEcCtD
Celecoxib—Immune system disorder—Methotrexate—rheumatoid arthritis	2.26e-05	0.000299	CcSEcCtD
Celecoxib—Abdominal pain—Hydrocortisone—rheumatoid arthritis	2.26e-05	0.000299	CcSEcCtD
Celecoxib—Body temperature increased—Hydrocortisone—rheumatoid arthritis	2.26e-05	0.000299	CcSEcCtD
Celecoxib—Mediastinal disorder—Methotrexate—rheumatoid arthritis	2.25e-05	0.000298	CcSEcCtD
Celecoxib—Hypertension—Prednisone—rheumatoid arthritis	2.25e-05	0.000297	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Dexamethasone—rheumatoid arthritis	2.22e-05	0.000294	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Betamethasone—rheumatoid arthritis	2.22e-05	0.000294	CcSEcCtD
Celecoxib—Arthralgia—Prednisone—rheumatoid arthritis	2.22e-05	0.000293	CcSEcCtD
Celecoxib—Myalgia—Prednisone—rheumatoid arthritis	2.22e-05	0.000293	CcSEcCtD
Celecoxib—Feeling abnormal—Triamcinolone—rheumatoid arthritis	2.22e-05	0.000293	CcSEcCtD
Celecoxib—Feeling abnormal—Methylprednisolone—rheumatoid arthritis	2.21e-05	0.000292	CcSEcCtD
Celecoxib—Anxiety—Prednisone—rheumatoid arthritis	2.21e-05	0.000292	CcSEcCtD
Celecoxib—Alopecia—Methotrexate—rheumatoid arthritis	2.21e-05	0.000292	CcSEcCtD
Celecoxib—Insomnia—Dexamethasone—rheumatoid arthritis	2.21e-05	0.000292	CcSEcCtD
Celecoxib—Insomnia—Betamethasone—rheumatoid arthritis	2.21e-05	0.000292	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	2.2e-05	0.000291	CcSEcCtD
Celecoxib—Diarrhoea—Cyclosporine—rheumatoid arthritis	2.2e-05	0.000291	CcSEcCtD
Celecoxib—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	2.19e-05	0.00029	CcSEcCtD
Celecoxib—Paraesthesia—Dexamethasone—rheumatoid arthritis	2.19e-05	0.00029	CcSEcCtD
Celecoxib—Paraesthesia—Betamethasone—rheumatoid arthritis	2.19e-05	0.00029	CcSEcCtD
Celecoxib—Mental disorder—Methotrexate—rheumatoid arthritis	2.19e-05	0.00029	CcSEcCtD
Celecoxib—Hypersensitivity—Prednisolone—rheumatoid arthritis	2.15e-05	0.000285	CcSEcCtD
Celecoxib—Dyspepsia—Dexamethasone—rheumatoid arthritis	2.15e-05	0.000284	CcSEcCtD
Celecoxib—Dyspepsia—Betamethasone—rheumatoid arthritis	2.15e-05	0.000284	CcSEcCtD
Celecoxib—Urticaria—Triamcinolone—rheumatoid arthritis	2.14e-05	0.000282	CcSEcCtD
Celecoxib—Urticaria—Methylprednisolone—rheumatoid arthritis	2.13e-05	0.000282	CcSEcCtD
Celecoxib—Dysgeusia—Methotrexate—rheumatoid arthritis	2.13e-05	0.000282	CcSEcCtD
Celecoxib—Body temperature increased—Triamcinolone—rheumatoid arthritis	2.13e-05	0.000281	CcSEcCtD
Celecoxib—Dizziness—Cyclosporine—rheumatoid arthritis	2.13e-05	0.000281	CcSEcCtD
Celecoxib—Anaphylactic shock—Prednisone—rheumatoid arthritis	2.13e-05	0.000281	CcSEcCtD
Celecoxib—Oedema—Prednisone—rheumatoid arthritis	2.13e-05	0.000281	CcSEcCtD
Celecoxib—Abdominal pain—Methylprednisolone—rheumatoid arthritis	2.12e-05	0.00028	CcSEcCtD
Celecoxib—Decreased appetite—Dexamethasone—rheumatoid arthritis	2.12e-05	0.00028	CcSEcCtD
Celecoxib—Decreased appetite—Betamethasone—rheumatoid arthritis	2.12e-05	0.00028	CcSEcCtD
Celecoxib—Infection—Prednisone—rheumatoid arthritis	2.11e-05	0.000279	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	2.11e-05	0.000279	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	2.11e-05	0.000279	CcSEcCtD
Celecoxib—Back pain—Methotrexate—rheumatoid arthritis	2.1e-05	0.000278	CcSEcCtD
Celecoxib—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	2.1e-05	0.000278	CcSEcCtD
Celecoxib—Fatigue—Dexamethasone—rheumatoid arthritis	2.1e-05	0.000278	CcSEcCtD
Celecoxib—Fatigue—Betamethasone—rheumatoid arthritis	2.1e-05	0.000278	CcSEcCtD
Celecoxib—Shock—Prednisone—rheumatoid arthritis	2.09e-05	0.000276	CcSEcCtD
Celecoxib—Nervous system disorder—Prednisone—rheumatoid arthritis	2.08e-05	0.000276	CcSEcCtD
Celecoxib—Tachycardia—Prednisone—rheumatoid arthritis	2.07e-05	0.000274	CcSEcCtD
Celecoxib—Skin disorder—Prednisone—rheumatoid arthritis	2.06e-05	0.000273	CcSEcCtD
Celecoxib—Hyperhidrosis—Prednisone—rheumatoid arthritis	2.05e-05	0.000272	CcSEcCtD
Celecoxib—Vision blurred—Methotrexate—rheumatoid arthritis	2.05e-05	0.000271	CcSEcCtD
Celecoxib—Asthenia—Hydrocortisone—rheumatoid arthritis	2.05e-05	0.000271	CcSEcCtD
Celecoxib—Vomiting—Cyclosporine—rheumatoid arthritis	2.04e-05	0.00027	CcSEcCtD
Celecoxib—Rash—Cyclosporine—rheumatoid arthritis	2.03e-05	0.000268	CcSEcCtD
Celecoxib—Anorexia—Prednisone—rheumatoid arthritis	2.03e-05	0.000268	CcSEcCtD
Celecoxib—Dermatitis—Cyclosporine—rheumatoid arthritis	2.02e-05	0.000268	CcSEcCtD
Celecoxib—Pruritus—Hydrocortisone—rheumatoid arthritis	2.02e-05	0.000267	CcSEcCtD
Celecoxib—Headache—Cyclosporine—rheumatoid arthritis	2.01e-05	0.000266	CcSEcCtD
Celecoxib—Anaemia—Methotrexate—rheumatoid arthritis	2.01e-05	0.000266	CcSEcCtD
Celecoxib—Feeling abnormal—Dexamethasone—rheumatoid arthritis	2.01e-05	0.000266	CcSEcCtD
Celecoxib—Feeling abnormal—Betamethasone—rheumatoid arthritis	2.01e-05	0.000266	CcSEcCtD
Celecoxib—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	2e-05	0.000264	CcSEcCtD
Celecoxib—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	2e-05	0.000264	CcSEcCtD
Celecoxib—Hypersensitivity—Triamcinolone—rheumatoid arthritis	1.98e-05	0.000262	CcSEcCtD
Celecoxib—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	1.98e-05	0.000261	CcSEcCtD
Celecoxib—Vertigo—Methotrexate—rheumatoid arthritis	1.96e-05	0.000259	CcSEcCtD
Celecoxib—Diarrhoea—Hydrocortisone—rheumatoid arthritis	1.95e-05	0.000258	CcSEcCtD
Celecoxib—Leukopenia—Methotrexate—rheumatoid arthritis	1.95e-05	0.000258	CcSEcCtD
Celecoxib—Urticaria—Dexamethasone—rheumatoid arthritis	1.94e-05	0.000256	CcSEcCtD
Celecoxib—Urticaria—Betamethasone—rheumatoid arthritis	1.94e-05	0.000256	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Prednisone—rheumatoid arthritis	1.94e-05	0.000256	CcSEcCtD
Celecoxib—Dizziness—Prednisolone—rheumatoid arthritis	1.93e-05	0.000256	CcSEcCtD
Celecoxib—Asthenia—Triamcinolone—rheumatoid arthritis	1.93e-05	0.000255	CcSEcCtD
Celecoxib—Abdominal pain—Betamethasone—rheumatoid arthritis	1.93e-05	0.000255	CcSEcCtD
Celecoxib—Abdominal pain—Dexamethasone—rheumatoid arthritis	1.93e-05	0.000255	CcSEcCtD
Celecoxib—Body temperature increased—Dexamethasone—rheumatoid arthritis	1.93e-05	0.000255	CcSEcCtD
Celecoxib—Body temperature increased—Betamethasone—rheumatoid arthritis	1.93e-05	0.000255	CcSEcCtD
Celecoxib—Asthenia—Methylprednisolone—rheumatoid arthritis	1.93e-05	0.000255	CcSEcCtD
Celecoxib—Insomnia—Prednisone—rheumatoid arthritis	1.92e-05	0.000254	CcSEcCtD
Celecoxib—Nausea—Cyclosporine—rheumatoid arthritis	1.91e-05	0.000252	CcSEcCtD
Celecoxib—Paraesthesia—Prednisone—rheumatoid arthritis	1.91e-05	0.000252	CcSEcCtD
Celecoxib—Pruritus—Triamcinolone—rheumatoid arthritis	1.9e-05	0.000252	CcSEcCtD
Celecoxib—Cough—Methotrexate—rheumatoid arthritis	1.9e-05	0.000251	CcSEcCtD
Celecoxib—Pruritus—Methylprednisolone—rheumatoid arthritis	1.9e-05	0.000251	CcSEcCtD
Celecoxib—Dizziness—Hydrocortisone—rheumatoid arthritis	1.89e-05	0.00025	CcSEcCtD
Celecoxib—Dyspepsia—Prednisone—rheumatoid arthritis	1.87e-05	0.000247	CcSEcCtD
Celecoxib—Chest pain—Methotrexate—rheumatoid arthritis	1.85e-05	0.000245	CcSEcCtD
Celecoxib—Arthralgia—Methotrexate—rheumatoid arthritis	1.85e-05	0.000245	CcSEcCtD
Celecoxib—Myalgia—Methotrexate—rheumatoid arthritis	1.85e-05	0.000245	CcSEcCtD
Celecoxib—Decreased appetite—Prednisone—rheumatoid arthritis	1.85e-05	0.000244	CcSEcCtD
Celecoxib—Rash—Prednisolone—rheumatoid arthritis	1.84e-05	0.000244	CcSEcCtD
Celecoxib—Dermatitis—Prednisolone—rheumatoid arthritis	1.84e-05	0.000244	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	1.84e-05	0.000243	CcSEcCtD
Celecoxib—Diarrhoea—Methylprednisolone—rheumatoid arthritis	1.84e-05	0.000243	CcSEcCtD
Celecoxib—Fatigue—Prednisone—rheumatoid arthritis	1.83e-05	0.000242	CcSEcCtD
Celecoxib—Headache—Prednisolone—rheumatoid arthritis	1.83e-05	0.000242	CcSEcCtD
Celecoxib—Constipation—Prednisone—rheumatoid arthritis	1.82e-05	0.00024	CcSEcCtD
Celecoxib—Vomiting—Hydrocortisone—rheumatoid arthritis	1.82e-05	0.00024	CcSEcCtD
Celecoxib—Rash—Hydrocortisone—rheumatoid arthritis	1.8e-05	0.000238	CcSEcCtD
Celecoxib—Dermatitis—Hydrocortisone—rheumatoid arthritis	1.8e-05	0.000238	CcSEcCtD
Celecoxib—Confusional state—Methotrexate—rheumatoid arthritis	1.79e-05	0.000237	CcSEcCtD
Celecoxib—Headache—Hydrocortisone—rheumatoid arthritis	1.79e-05	0.000237	CcSEcCtD
Celecoxib—Dizziness—Triamcinolone—rheumatoid arthritis	1.78e-05	0.000235	CcSEcCtD
Celecoxib—Anaphylactic shock—Methotrexate—rheumatoid arthritis	1.78e-05	0.000235	CcSEcCtD
Celecoxib—Dizziness—Methylprednisolone—rheumatoid arthritis	1.77e-05	0.000235	CcSEcCtD
Celecoxib—Infection—Methotrexate—rheumatoid arthritis	1.76e-05	0.000233	CcSEcCtD
Celecoxib—Feeling abnormal—Prednisone—rheumatoid arthritis	1.75e-05	0.000232	CcSEcCtD
Celecoxib—Asthenia—Dexamethasone—rheumatoid arthritis	1.75e-05	0.000231	CcSEcCtD
Celecoxib—Asthenia—Betamethasone—rheumatoid arthritis	1.75e-05	0.000231	CcSEcCtD
Celecoxib—Nervous system disorder—Methotrexate—rheumatoid arthritis	1.74e-05	0.00023	CcSEcCtD
Celecoxib—Thrombocytopenia—Methotrexate—rheumatoid arthritis	1.74e-05	0.00023	CcSEcCtD
Celecoxib—Gastrointestinal pain—Prednisone—rheumatoid arthritis	1.74e-05	0.00023	CcSEcCtD
Celecoxib—Nausea—Prednisolone—rheumatoid arthritis	1.74e-05	0.00023	CcSEcCtD
Celecoxib—Pruritus—Dexamethasone—rheumatoid arthritis	1.73e-05	0.000228	CcSEcCtD
Celecoxib—Pruritus—Betamethasone—rheumatoid arthritis	1.73e-05	0.000228	CcSEcCtD
Celecoxib—Skin disorder—Methotrexate—rheumatoid arthritis	1.73e-05	0.000228	CcSEcCtD
Celecoxib—Hyperhidrosis—Methotrexate—rheumatoid arthritis	1.72e-05	0.000227	CcSEcCtD
Celecoxib—Vomiting—Triamcinolone—rheumatoid arthritis	1.71e-05	0.000226	CcSEcCtD
Celecoxib—Vomiting—Methylprednisolone—rheumatoid arthritis	1.71e-05	0.000226	CcSEcCtD
Celecoxib—Nausea—Hydrocortisone—rheumatoid arthritis	1.7e-05	0.000224	CcSEcCtD
Celecoxib—Rash—Triamcinolone—rheumatoid arthritis	1.7e-05	0.000224	CcSEcCtD
Celecoxib—Dermatitis—Triamcinolone—rheumatoid arthritis	1.69e-05	0.000224	CcSEcCtD
Celecoxib—Anorexia—Methotrexate—rheumatoid arthritis	1.69e-05	0.000224	CcSEcCtD
Celecoxib—Rash—Methylprednisolone—rheumatoid arthritis	1.69e-05	0.000224	CcSEcCtD
Celecoxib—Dermatitis—Methylprednisolone—rheumatoid arthritis	1.69e-05	0.000223	CcSEcCtD
Celecoxib—Urticaria—Prednisone—rheumatoid arthritis	1.69e-05	0.000223	CcSEcCtD
Celecoxib—Headache—Triamcinolone—rheumatoid arthritis	1.68e-05	0.000223	CcSEcCtD
Celecoxib—Headache—Methylprednisolone—rheumatoid arthritis	1.68e-05	0.000222	CcSEcCtD
Celecoxib—Abdominal pain—Prednisone—rheumatoid arthritis	1.68e-05	0.000222	CcSEcCtD
Celecoxib—Body temperature increased—Prednisone—rheumatoid arthritis	1.68e-05	0.000222	CcSEcCtD
Celecoxib—Diarrhoea—Betamethasone—rheumatoid arthritis	1.67e-05	0.000221	CcSEcCtD
Celecoxib—Diarrhoea—Dexamethasone—rheumatoid arthritis	1.67e-05	0.000221	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Methotrexate—rheumatoid arthritis	1.62e-05	0.000214	CcSEcCtD
Celecoxib—Dizziness—Dexamethasone—rheumatoid arthritis	1.61e-05	0.000213	CcSEcCtD
Celecoxib—Dizziness—Betamethasone—rheumatoid arthritis	1.61e-05	0.000213	CcSEcCtD
Celecoxib—Insomnia—Methotrexate—rheumatoid arthritis	1.61e-05	0.000212	CcSEcCtD
Celecoxib—Nausea—Triamcinolone—rheumatoid arthritis	1.6e-05	0.000211	CcSEcCtD
Celecoxib—Paraesthesia—Methotrexate—rheumatoid arthritis	1.59e-05	0.000211	CcSEcCtD
Celecoxib—Nausea—Methylprednisolone—rheumatoid arthritis	1.59e-05	0.000211	CcSEcCtD
Celecoxib—Dyspnoea—Methotrexate—rheumatoid arthritis	1.58e-05	0.000209	CcSEcCtD
Celecoxib—Somnolence—Methotrexate—rheumatoid arthritis	1.58e-05	0.000209	CcSEcCtD
Celecoxib—Hypersensitivity—Prednisone—rheumatoid arthritis	1.57e-05	0.000207	CcSEcCtD
Celecoxib—Dyspepsia—Methotrexate—rheumatoid arthritis	1.56e-05	0.000207	CcSEcCtD
Celecoxib—Vomiting—Betamethasone—rheumatoid arthritis	1.55e-05	0.000205	CcSEcCtD
Celecoxib—Vomiting—Dexamethasone—rheumatoid arthritis	1.55e-05	0.000205	CcSEcCtD
Celecoxib—Decreased appetite—Methotrexate—rheumatoid arthritis	1.54e-05	0.000204	CcSEcCtD
Celecoxib—Rash—Dexamethasone—rheumatoid arthritis	1.54e-05	0.000203	CcSEcCtD
Celecoxib—Rash—Betamethasone—rheumatoid arthritis	1.54e-05	0.000203	CcSEcCtD
Celecoxib—Dermatitis—Betamethasone—rheumatoid arthritis	1.54e-05	0.000203	CcSEcCtD
Celecoxib—Dermatitis—Dexamethasone—rheumatoid arthritis	1.54e-05	0.000203	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	1.53e-05	0.000203	CcSEcCtD
Celecoxib—Fatigue—Methotrexate—rheumatoid arthritis	1.53e-05	0.000202	CcSEcCtD
Celecoxib—Headache—Betamethasone—rheumatoid arthritis	1.53e-05	0.000202	CcSEcCtD
Celecoxib—Headache—Dexamethasone—rheumatoid arthritis	1.53e-05	0.000202	CcSEcCtD
Celecoxib—Asthenia—Prednisone—rheumatoid arthritis	1.52e-05	0.000202	CcSEcCtD
Celecoxib—Pruritus—Prednisone—rheumatoid arthritis	1.5e-05	0.000199	CcSEcCtD
Celecoxib—Feeling abnormal—Methotrexate—rheumatoid arthritis	1.46e-05	0.000194	CcSEcCtD
Celecoxib—Diarrhoea—Prednisone—rheumatoid arthritis	1.45e-05	0.000192	CcSEcCtD
Celecoxib—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	1.45e-05	0.000192	CcSEcCtD
Celecoxib—Nausea—Betamethasone—rheumatoid arthritis	1.45e-05	0.000192	CcSEcCtD
Celecoxib—Nausea—Dexamethasone—rheumatoid arthritis	1.45e-05	0.000192	CcSEcCtD
Celecoxib—Urticaria—Methotrexate—rheumatoid arthritis	1.41e-05	0.000187	CcSEcCtD
Celecoxib—Dizziness—Prednisone—rheumatoid arthritis	1.41e-05	0.000186	CcSEcCtD
Celecoxib—Abdominal pain—Methotrexate—rheumatoid arthritis	1.4e-05	0.000186	CcSEcCtD
Celecoxib—Body temperature increased—Methotrexate—rheumatoid arthritis	1.4e-05	0.000186	CcSEcCtD
Celecoxib—Vomiting—Prednisone—rheumatoid arthritis	1.35e-05	0.000179	CcSEcCtD
Celecoxib—Rash—Prednisone—rheumatoid arthritis	1.34e-05	0.000177	CcSEcCtD
Celecoxib—Dermatitis—Prednisone—rheumatoid arthritis	1.34e-05	0.000177	CcSEcCtD
Celecoxib—Headache—Prednisone—rheumatoid arthritis	1.33e-05	0.000176	CcSEcCtD
Celecoxib—Hypersensitivity—Methotrexate—rheumatoid arthritis	1.31e-05	0.000173	CcSEcCtD
Celecoxib—Asthenia—Methotrexate—rheumatoid arthritis	1.27e-05	0.000168	CcSEcCtD
Celecoxib—Nausea—Prednisone—rheumatoid arthritis	1.26e-05	0.000167	CcSEcCtD
Celecoxib—Pruritus—Methotrexate—rheumatoid arthritis	1.26e-05	0.000166	CcSEcCtD
Celecoxib—Diarrhoea—Methotrexate—rheumatoid arthritis	1.22e-05	0.000161	CcSEcCtD
Celecoxib—Dizziness—Methotrexate—rheumatoid arthritis	1.17e-05	0.000155	CcSEcCtD
Celecoxib—Vomiting—Methotrexate—rheumatoid arthritis	1.13e-05	0.000149	CcSEcCtD
Celecoxib—Rash—Methotrexate—rheumatoid arthritis	1.12e-05	0.000148	CcSEcCtD
Celecoxib—Dermatitis—Methotrexate—rheumatoid arthritis	1.12e-05	0.000148	CcSEcCtD
Celecoxib—Headache—Methotrexate—rheumatoid arthritis	1.11e-05	0.000147	CcSEcCtD
Celecoxib—Nausea—Methotrexate—rheumatoid arthritis	1.05e-05	0.000139	CcSEcCtD
Celecoxib—CYP2C9—Metabolism—PLD4—rheumatoid arthritis	3.66e-06	5.56e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—HLA-DQB1—rheumatoid arthritis	3.64e-06	5.53e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—SLC11A1—rheumatoid arthritis	3.63e-06	5.52e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—FADS2—rheumatoid arthritis	3.62e-06	5.5e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—NFATC1—rheumatoid arthritis	3.6e-06	5.47e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TRAF6—rheumatoid arthritis	3.58e-06	5.43e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—SH2B3—rheumatoid arthritis	3.58e-06	5.43e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ACAN—rheumatoid arthritis	3.57e-06	5.42e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—GZMB—rheumatoid arthritis	3.56e-06	5.4e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ACAN—rheumatoid arthritis	3.54e-06	5.37e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—PTK2—rheumatoid arthritis	3.52e-06	5.35e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—LEP—rheumatoid arthritis	3.52e-06	5.35e-05	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—VDR—rheumatoid arthritis	3.52e-06	5.34e-05	CbGpPWpGaD
Celecoxib—CA4—Metabolism—ALB—rheumatoid arthritis	3.52e-06	5.34e-05	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—IL6—rheumatoid arthritis	3.49e-06	5.3e-05	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—rheumatoid arthritis	3.48e-06	5.28e-05	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—IL1B—rheumatoid arthritis	3.47e-06	5.27e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—PTK2—rheumatoid arthritis	3.47e-06	5.27e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—CD4—rheumatoid arthritis	3.47e-06	5.27e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL1A—rheumatoid arthritis	3.46e-06	5.25e-05	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—IL2—rheumatoid arthritis	3.46e-06	5.25e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL18—rheumatoid arthritis	3.45e-06	5.24e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CCL3—rheumatoid arthritis	3.45e-06	5.24e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CXCL2—rheumatoid arthritis	3.45e-06	5.24e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—PTGS2—rheumatoid arthritis	3.45e-06	5.23e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CD40LG—rheumatoid arthritis	3.44e-06	5.22e-05	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—IL2—rheumatoid arthritis	3.44e-06	5.22e-05	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—IL2—rheumatoid arthritis	3.43e-06	5.21e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CSF2—rheumatoid arthritis	3.4e-06	5.17e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CD8A—rheumatoid arthritis	3.4e-06	5.17e-05	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—IL6—rheumatoid arthritis	3.39e-06	5.15e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—SAA1—rheumatoid arthritis	3.38e-06	5.13e-05	CbGpPWpGaD
Celecoxib—CA2—Metabolism—ALB—rheumatoid arthritis	3.37e-06	5.12e-05	CbGpPWpGaD
Celecoxib—CA4—Metabolism—NOS3—rheumatoid arthritis	3.36e-06	5.11e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—CD4—rheumatoid arthritis	3.36e-06	5.09e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—SLC25A12—rheumatoid arthritis	3.35e-06	5.09e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—CSF2—rheumatoid arthritis	3.35e-06	5.09e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—NCF2—rheumatoid arthritis	3.35e-06	5.09e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—BGN—rheumatoid arthritis	3.33e-06	5.06e-05	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—VEGFA—rheumatoid arthritis	3.33e-06	5.05e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—SLC25A12—rheumatoid arthritis	3.33e-06	5.05e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—FN1—rheumatoid arthritis	3.32e-06	5.04e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—AGER—rheumatoid arthritis	3.32e-06	5.04e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IL6ST—rheumatoid arthritis	3.31e-06	5.02e-05	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—MMP9—rheumatoid arthritis	3.31e-06	5.02e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—NCF1—rheumatoid arthritis	3.31e-06	5.02e-05	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—NFKB1—rheumatoid arthritis	3.27e-06	4.97e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—HLA-B—rheumatoid arthritis	3.27e-06	4.97e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GC—rheumatoid arthritis	3.26e-06	4.95e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PTGES—rheumatoid arthritis	3.26e-06	4.95e-05	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—NFKB1—rheumatoid arthritis	3.24e-06	4.92e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GC—rheumatoid arthritis	3.24e-06	4.91e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PTGES—rheumatoid arthritis	3.24e-06	4.91e-05	CbGpPWpGaD
Celecoxib—CA2—Metabolism—NOS3—rheumatoid arthritis	3.23e-06	4.9e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—MED1—rheumatoid arthritis	3.22e-06	4.89e-05	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—MAPK8—rheumatoid arthritis	3.19e-06	4.84e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CD80—rheumatoid arthritis	3.19e-06	4.84e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—IL6—rheumatoid arthritis	3.18e-06	4.83e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CD28—rheumatoid arthritis	3.18e-06	4.83e-05	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—NR3C1—rheumatoid arthritis	3.17e-06	4.81e-05	CbGpPWpGaD
Celecoxib—CA9—Metabolism—POMC—rheumatoid arthritis	3.12e-06	4.73e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—SAA1—rheumatoid arthritis	3.08e-06	4.68e-05	CbGpPWpGaD
Celecoxib—CA4—Metabolism—PTGS2—rheumatoid arthritis	3.08e-06	4.67e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Biological oxidations—POMC—rheumatoid arthritis	3.07e-06	4.66e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—ALOX5—rheumatoid arthritis	3.07e-06	4.66e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL2RA—rheumatoid arthritis	3.07e-06	4.66e-05	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—rheumatoid arthritis	3.07e-06	4.66e-05	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—TGFB1—rheumatoid arthritis	3.06e-06	4.64e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—C3—rheumatoid arthritis	3.04e-06	4.62e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PLB1—rheumatoid arthritis	3.03e-06	4.61e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—HLA-A—rheumatoid arthritis	3.03e-06	4.6e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—POMC—rheumatoid arthritis	3.03e-06	4.59e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—IL2RA—rheumatoid arthritis	3.02e-06	4.59e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—NCF1—rheumatoid arthritis	3.02e-06	4.58e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PLB1—rheumatoid arthritis	3.01e-06	4.57e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—ACP5—rheumatoid arthritis	3e-06	4.55e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—B3GNT2—rheumatoid arthritis	3e-06	4.55e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—UBE2D1—rheumatoid arthritis	2.99e-06	4.54e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—ENO1—rheumatoid arthritis	2.99e-06	4.53e-05	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—VEGFA—rheumatoid arthritis	2.97e-06	4.51e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CCL2—rheumatoid arthritis	2.96e-06	4.49e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IL6R—rheumatoid arthritis	2.95e-06	4.48e-05	CbGpPWpGaD
Celecoxib—CA2—Metabolism—PTGS2—rheumatoid arthritis	2.95e-06	4.48e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CXCL12—rheumatoid arthritis	2.94e-06	4.46e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—BDKRB2—rheumatoid arthritis	2.94e-06	4.46e-05	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—VEGFA—rheumatoid arthritis	2.92e-06	4.44e-05	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—VEGFA—rheumatoid arthritis	2.91e-06	4.42e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—ADRBK1—rheumatoid arthritis	2.9e-06	4.41e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CD28—rheumatoid arthritis	2.9e-06	4.4e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CRP—rheumatoid arthritis	2.89e-06	4.39e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—NFKB1—rheumatoid arthritis	2.89e-06	4.39e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—MMP1—rheumatoid arthritis	2.88e-06	4.38e-05	CbGpPWpGaD
Celecoxib—CA9—Metabolism—ALB—rheumatoid arthritis	2.84e-06	4.31e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—MAPK8—rheumatoid arthritis	2.84e-06	4.31e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—TLR4—rheumatoid arthritis	2.77e-06	4.21e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—HLA-DRB1—rheumatoid arthritis	2.77e-06	4.21e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—RASGRP1—rheumatoid arthritis	2.74e-06	4.16e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—UBE2D1—rheumatoid arthritis	2.73e-06	4.15e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—SYK—rheumatoid arthritis	2.73e-06	4.14e-05	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—TGFB1—rheumatoid arthritis	2.73e-06	4.14e-05	CbGpPWpGaD
Celecoxib—CA9—Metabolism—NOS3—rheumatoid arthritis	2.72e-06	4.13e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	2.7e-06	4.1e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—BGN—rheumatoid arthritis	2.7e-06	4.09e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—TYK2—rheumatoid arthritis	2.69e-06	4.08e-05	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—TGFB1—rheumatoid arthritis	2.68e-06	4.07e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PRKCQ—rheumatoid arthritis	2.68e-06	4.07e-05	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—TGFB1—rheumatoid arthritis	2.68e-06	4.06e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—MED1—rheumatoid arthritis	2.66e-06	4.04e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL6ST—rheumatoid arthritis	2.66e-06	4.04e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—ICAM1—rheumatoid arthritis	2.66e-06	4.04e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—ADRBK1—rheumatoid arthritis	2.65e-06	4.02e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—NOS3—rheumatoid arthritis	2.64e-06	4.01e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—MED1—rheumatoid arthritis	2.64e-06	4e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—FN1—rheumatoid arthritis	2.63e-06	4e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—STAT1—rheumatoid arthritis	2.63e-06	4e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—NOS2—rheumatoid arthritis	2.6e-06	3.95e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CXCL10—rheumatoid arthritis	2.59e-06	3.94e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CD80—rheumatoid arthritis	2.56e-06	3.89e-05	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—TNF—rheumatoid arthritis	2.55e-06	3.87e-05	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—TP53—rheumatoid arthritis	2.52e-06	3.82e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—ENO1—rheumatoid arthritis	2.5e-06	3.8e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—TGFB1—rheumatoid arthritis	2.49e-06	3.78e-05	CbGpPWpGaD
Celecoxib—CA9—Metabolism—PTGS2—rheumatoid arthritis	2.49e-06	3.77e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—ALOX5—rheumatoid arthritis	2.48e-06	3.77e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—B3GNT2—rheumatoid arthritis	2.47e-06	3.75e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ACP5—rheumatoid arthritis	2.47e-06	3.75e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	2.46e-06	3.73e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—B3GNT2—rheumatoid arthritis	2.45e-06	3.72e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ACP5—rheumatoid arthritis	2.45e-06	3.72e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—PRKCQ—rheumatoid arthritis	2.44e-06	3.71e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PLD4—rheumatoid arthritis	2.42e-06	3.67e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—STAT1—rheumatoid arthritis	2.4e-06	3.64e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL6R—rheumatoid arthritis	2.37e-06	3.6e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—MMP3—rheumatoid arthritis	2.37e-06	3.59e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CXCL8—rheumatoid arthritis	2.34e-06	3.55e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ACAN—rheumatoid arthritis	2.33e-06	3.54e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PTK2—rheumatoid arthritis	2.28e-06	3.46e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IL2—rheumatoid arthritis	2.24e-06	3.4e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CCL5—rheumatoid arthritis	2.23e-06	3.39e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—BGN—rheumatoid arthritis	2.23e-06	3.38e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—IL6—rheumatoid arthritis	2.23e-06	3.38e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—BGN—rheumatoid arthritis	2.21e-06	3.35e-05	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—TP53—rheumatoid arthritis	2.2e-06	3.34e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CSF2—rheumatoid arthritis	2.2e-06	3.34e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—SLC25A12—rheumatoid arthritis	2.19e-06	3.33e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	2.18e-06	3.31e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—TYK2—rheumatoid arthritis	2.16e-06	3.28e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GC—rheumatoid arthritis	2.13e-06	3.24e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PTGES—rheumatoid arthritis	2.13e-06	3.24e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—MMP9—rheumatoid arthritis	2.12e-06	3.21e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—NFKB1—rheumatoid arthritis	2.09e-06	3.18e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—NOS3—rheumatoid arthritis	2.09e-06	3.17e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—SPP1—rheumatoid arthritis	2.07e-06	3.14e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—MAPK8—rheumatoid arthritis	2.06e-06	3.13e-05	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—IL6—rheumatoid arthritis	2.05e-06	3.12e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ALOX5—rheumatoid arthritis	2.05e-06	3.11e-05	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—IL6—rheumatoid arthritis	2.03e-06	3.09e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ALOX5—rheumatoid arthritis	2.03e-06	3.08e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IFNG—rheumatoid arthritis	2.02e-06	3.07e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—ENO1—rheumatoid arthritis	2.02e-06	3.07e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CCR5—rheumatoid arthritis	2.01e-06	3.05e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PLB1—rheumatoid arthritis	1.98e-06	3.01e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IL2RA—rheumatoid arthritis	1.98e-06	3.01e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—C3—rheumatoid arthritis	1.97e-06	2.99e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CD4—rheumatoid arthritis	1.95e-06	2.97e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—VEGFA—rheumatoid arthritis	1.9e-06	2.89e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—IL6—rheumatoid arthritis	1.88e-06	2.85e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CCR5—rheumatoid arthritis	1.84e-06	2.79e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—LEP—rheumatoid arthritis	1.83e-06	2.78e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—IL6—rheumatoid arthritis	1.81e-06	2.75e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL1B—rheumatoid arthritis	1.81e-06	2.74e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CAT—rheumatoid arthritis	1.8e-06	2.73e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL2—rheumatoid arthritis	1.8e-06	2.73e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—MTHFR—rheumatoid arthritis	1.79e-06	2.72e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—HLA-A—rheumatoid arthritis	1.79e-06	2.72e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	1.79e-06	2.71e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—IL2—rheumatoid arthritis	1.77e-06	2.69e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—TGFB1—rheumatoid arthritis	1.75e-06	2.65e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	1.74e-06	2.64e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—MED1—rheumatoid arthritis	1.74e-06	2.64e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—FN1—rheumatoid arthritis	1.73e-06	2.62e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IL6ST—rheumatoid arthritis	1.72e-06	2.61e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—NFKB1—rheumatoid arthritis	1.68e-06	2.56e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ENO1—rheumatoid arthritis	1.67e-06	2.54e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ENO1—rheumatoid arthritis	1.66e-06	2.51e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—MAPK8—rheumatoid arthritis	1.66e-06	2.51e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CD80—rheumatoid arthritis	1.66e-06	2.51e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	1.63e-06	2.47e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ACP5—rheumatoid arthritis	1.62e-06	2.45e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—B3GNT2—rheumatoid arthritis	1.62e-06	2.45e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—POMC—rheumatoid arthritis	1.57e-06	2.39e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—IL6ST—rheumatoid arthritis	1.57e-06	2.38e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—NOS2—rheumatoid arthritis	1.56e-06	2.36e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CCL2—rheumatoid arthritis	1.54e-06	2.34e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IL6R—rheumatoid arthritis	1.53e-06	2.33e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CD80—rheumatoid arthritis	1.51e-06	2.29e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—VEGFA—rheumatoid arthritis	1.51e-06	2.29e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—MTHFR—rheumatoid arthritis	1.5e-06	2.28e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CAT—rheumatoid arthritis	1.46e-06	2.21e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—BGN—rheumatoid arthritis	1.46e-06	2.21e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—TP53—rheumatoid arthritis	1.44e-06	2.18e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	1.43e-06	2.16e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—IL6R—rheumatoid arthritis	1.4e-06	2.12e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TYK2—rheumatoid arthritis	1.4e-06	2.12e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—TGFB1—rheumatoid arthritis	1.38e-06	2.1e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—NOS3—rheumatoid arthritis	1.37e-06	2.08e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ALOX5—rheumatoid arthritis	1.34e-06	2.03e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IL6—rheumatoid arthritis	1.32e-06	2e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—TYK2—rheumatoid arthritis	1.27e-06	1.94e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—NOS3—rheumatoid arthritis	1.25e-06	1.9e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CXCL8—rheumatoid arthritis	1.22e-06	1.85e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—MTHFR—rheumatoid arthritis	1.22e-06	1.85e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CAT—rheumatoid arthritis	1.2e-06	1.83e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—POMC—rheumatoid arthritis	1.2e-06	1.82e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CAT—rheumatoid arthritis	1.19e-06	1.81e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IL2—rheumatoid arthritis	1.16e-06	1.76e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CD4—rheumatoid arthritis	1.15e-06	1.75e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—TP53—rheumatoid arthritis	1.14e-06	1.73e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—MMP9—rheumatoid arthritis	1.1e-06	1.67e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—ALB—rheumatoid arthritis	1.1e-06	1.66e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ENO1—rheumatoid arthritis	1.09e-06	1.66e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—NFKB1—rheumatoid arthritis	1.09e-06	1.65e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—MAPK8—rheumatoid arthritis	1.07e-06	1.62e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL6—rheumatoid arthritis	1.06e-06	1.6e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—NOS3—rheumatoid arthritis	1.05e-06	1.59e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—MTHFR—rheumatoid arthritis	1e-06	1.52e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—MTHFR—rheumatoid arthritis	9.95e-07	1.51e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—VEGFA—rheumatoid arthritis	9.88e-07	1.5e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—POMC—rheumatoid arthritis	9.72e-07	1.48e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TGFB1—rheumatoid arthritis	9.07e-07	1.38e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—NOS3—rheumatoid arthritis	8.48e-07	1.29e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—TGFB1—rheumatoid arthritis	8.27e-07	1.26e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—POMC—rheumatoid arthritis	8.03e-07	1.22e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—POMC—rheumatoid arthritis	7.96e-07	1.21e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CAT—rheumatoid arthritis	7.86e-07	1.19e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PTGS2—rheumatoid arthritis	7.75e-07	1.18e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TP53—rheumatoid arthritis	7.47e-07	1.13e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ALB—rheumatoid arthritis	7.32e-07	1.11e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ALB—rheumatoid arthritis	7.25e-07	1.1e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—NOS3—rheumatoid arthritis	7e-07	1.06e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—NOS3—rheumatoid arthritis	6.94e-07	1.05e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IL6—rheumatoid arthritis	6.83e-07	1.04e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—MTHFR—rheumatoid arthritis	6.56e-07	9.96e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PTGS2—rheumatoid arthritis	6.4e-07	9.72e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PTGS2—rheumatoid arthritis	6.35e-07	9.63e-06	CbGpPWpGaD
Celecoxib—PTGS2—Disease—IL6—rheumatoid arthritis	6.23e-07	9.46e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—POMC—rheumatoid arthritis	5.25e-07	7.97e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ALB—rheumatoid arthritis	4.78e-07	7.26e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—NOS3—rheumatoid arthritis	4.58e-07	6.95e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PTGS2—rheumatoid arthritis	4.19e-07	6.35e-06	CbGpPWpGaD
